Top 5 Managed Healthcare Companies To Invest In 2014

Lynne Sladky/APA construction worker at the site of the SoMa at Brickell apartment building in downtown Miami. WASHINGTON -- U.S. service firms grew more quickly last month as production, hiring and new orders increased, adding to signs that the economy is accelerating after slipping at the start of the year. The Institute for Supply Management said Wednesday that its service-sector index rose to 56.3 in May, the best reading since August 2013. The figure is an improvement from the 55.2 posted in April. Any figure above 50 indicates expansion. The report points to solid growth after a brutal winter caused the economy to shrink 1 percent during the January-March quarter. The gains in new orders and the backlog of existing orders suggest a faster rate of hiring in the months ahead as businesses rush to meet the demand. "With this level of activity and new orders in the pipeline, employment is going to have to come up," said Anthony Nieves, chairman of the ISM's services survey committee. "There is no way that companies will be able to sustain a good level of output if they don't have the bodies to do it." The services survey covers businesses that employ 90 percent of the workforce, including retail, construction, health care and financial services firms. ISM is a trade group of purchasing managers. New orders rose for the fifth consecutive month, up 2.3 points to 60.5 and the highest reading since January 2011. The production component also climbed to 62.1, its strongest level since December 2010. Of the 18 industries surveyed in the report, only the mining sector contracted last month. Several other economic reports indicate that the economy is gaining momentum. The ISM's separate survey of manufacturers on Monday rose to 55.4 in May. Both production and orders notched solid gains. Auto sales improved in May as well. On Tuesday, Chrysler, General Motors, Nissan and Toyota all reported double-digit sales gains year-over-year. Ford's sales rose a better-than-expected 3 percent, while Hyundai's were up 4 percent. The government issues its May jobs report on Friday. Employers added 288,000 jobs in April, and the unemployment rate fell to 6.3 percent. Economists expect 220,000 jobs were created in May, according to a FactSet survey. But payroll processor ADP said Wednesday that private employers pulled back on hiring in May, adding just 179,000 jobs.

Hot Gold Stocks To Own Right Now: LG Display Co Ltd (LPL)

LG Display Co., Ltd. (LG Display), incorporated in 1985, manufactures thin-film transistor liquid crystal display (TFT-LCD) panels in a range of sizes and specifications primarily for use in televisions, notebook computers and desktop monitors, and the Company is a suppliers of high-definition television panels. The Company also manufactures TFT-LCDs for other application products, such as mobile phones, certain types of tablet personal computers and industrial and other applications, including entertainment systems, automotives, portable navigation devices, e-books, digital photo displays and medical diagnostic equipment. During the year ended December 31, 2010, LG Display sold a total of 160.4 million large-size (nine-inch or larger) TFT-LCD panels. In addition to TFT-LCD panels, the Company also manufactures organic light-emitting diode (OLEDs) and flexible displays. As of March 31, 2011, the Company held a total of 15,049 patents, including 6,724 in Korea and 8,325 in other countries, including in the United States, China, Japan, Germany, France, Great Britain and Taiwan.

In May 2010, the Company purchased the liquid crystal display module division of LG Innotek Co., Ltd. (LG Innotek), a subsidiary of LG Electronics. In June 2010, the Company entered into a joint venture agreement with Iriver Ltd. to establish L&I Electronic Technology (Dongguan) Ltd. in Dongguan, China. In August 2010, the Company entered into a joint venture agreement with Everlight Electronics Co., Ltd. and AmTRAN Technology Co., Ltd., to establish Eralite Optoelectronics (Jiangsu) Co., Ltd.

As of December 31, 2010, the Company operated 12 panel fabrication facilities (five in Paju, Korea and seven in Gumi, Korea, and including expansions of certain facilities) and a total of nine module facilities (three in Nanjing, China, two in Guangzhou, China and one each in Gumi and Paju, Korea, Yantai, China and Wroclaw, Poland). In 2010, its display panels were included in products sold by LG Electronics, Appl! e, Toshiba, Dell, Hewlett-Packard, Philips Electronics.

Televisions

The Company�� television panels range from 15 inches to 72-inch wide-format in size. The Company�� product portfolio includes panels of various sizes, such as 17-inch, 19-inch, 20-inch, 22-inch, 26-inch, 32-inch, 37-inch, 42-inch, 47-inch and 55-inch panels.As of december 31, 2010, 32-inch, 37-inch, 42-inch and 47-inch wide-format panels consists of principal products in this category in terms of sales revenue and sales volume.

Desktop Monitors

The Company�� desktop monitor display panels range from 15 inches to 30-inch wide-format in size in a variety of display resolutions and formats. In 2010, 19-inch and 21.5-inch display panels were its principal products in terms of sales revenue and sales volume in this category.

Notebook Computers

The Company�� display panels for notebook computers range from seven inches to 20.1-inch wide-format in size in a variety of display formats. In 2010, 15.6-inch, 9.7-inch and 14-inch panels were its principal products in this category.

Mobile and Other Applications

The Company�� product portfolio also includes panels for mobile and other applications, which utilize a wide array of display panel sizes, including mobile phones, certain types of tablet personal computers and industrial and other applications, including entertainment systems, automotives, portable navigation devices, e-books, digital photo displays and medical diagnostic equipment. TFT-LCD panels that are nine inches and smaller are referred to as small and medium-size panels, with those smaller than four inches being considered small-size panels. In 2010, sales of small-size panels constituted a significant majority in terms of both sales revenue and sales volume in the mobile and other applications category. Some of the panels the Company produces for industrial products, such as medical diagnostic equipment.

T! he Compan! y competes with Samsung Electronics, Samsung Mobile Display and Hydis Technologies, AU Optronics, Chimei Innolux, Chunghwa Picture Tubes, HannStar, Sharp, Hitachi, TMDisplay, Mitsubishi, IPS-Alpha, SAVIC, Infovision and BOE-OT.

Advisors' Opinion:

• [By Steve Symington]

  Another long-term licensing deal
  Next,�I think it's safe to assume a similar long-term deal will be signed in 2014 with LG Display (NYSE: LPL  ) .

Top 5 Managed Healthcare Companies To Invest In 2014: ONYX Pharmaceuticals Inc.(ONXX)

Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally. The company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., develops and markets Nexavar (sorafenib) tablet, a multiple kinase inhibitor for the treatment of liver cancer and advanced kidney cancer. It is also conducting Phase III clinical trial on Nexavar for the treatment of kidney, liver, lung, thyroid, breast, and non-small cell lung cancers; clinical trials on carfilzomib, a proteasome inhibitor for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors; and Phase Ib/II clinical trial on Oprozomib, an oral proteasome inhibitor. In addition, Onyx Pharmaceuticals, Inc. is developing ONX 0914, an immunoproteasome inhibitor, which is in preclinical stage for the treatment of autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease, and lupus. Further, the company, through its collaboration agreement with Bayer HealthCare Pharmaceuticals, Inc., is conducting clinical trials on Regorafenib, a multi-kinase inhibitor to treat metastatic colorectal cancer and gastrointestinal stromal tumors. It has a collaboration agreement with Warner-Lambert Company to discover and commercialize small molecule drugs that restore control of or intervene in the misregulated cell cycle in tumor cells. The company also has development and license agreements with BTG International Limited for the development and commercialization of ONX 0801, a novel targeted oncology compound; and Ono Pharmaceutical Co., Ltd. to develop and commercialize carfilzomib and Oprozomib for oncology indications in Japan. Onyx Pharmaceuticals, Inc. was founded in 1992 and is headquartered in South San Francisco, California.

Advisors' Opinion:

• [By Sean Williams]

  If obesity rates don't decline, a biopharmaceutical company like Onyx Pharmaceuticals (NASDAQ: ONXX  ) , which has an oral medication known as Stivarga to treat advanced colorectal cancer, will clearly benefit. Onyx projects that Stivarga, which works by inhibiting membrane-bound and intracellular kinases, could have peak sales in excess of $1 billion. Onyx receives a 20% royalty interest on net sales of the drug, with the remainder going to partner Bayer.

• [By Alex Planes]

  Palboclib, a treatment for breast cancer, which Pfizer licenses from Onyx Pharmaceuticals (NASDAQ: ONXX  ) recently received breakthrough therapy designation status from the Food and Drug Administration this year. �On the other hand, Pfizer's new chronic myeloid leukemia drug Bosulif has been rejected by the U.K.'s cost agency National Institute for Health and Clinical Excellence. You win some, you lose some.

• [By Jon C. Ogg]

  Questcor Pharmaceuticals Inc. (NASDAQ: QCOR) and Under Armour Inc. (NYSE: UA) may seem to have little to nothing in common on the surface. Questcor is in the pharmaceutical business, while Under Armour is the sports apparel and casual wear business. The world has now seen that Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) is being acquired for some $10.4 billion. The commonality between Questcor and Under Armour is that they were featured on the same recent high growth list of public companies expected to double their revenues over the next two to four years.

• [By Rich Smith]

  Finally, Standpoint argues that Pfizer appears tempted to get into a bidding war with Amgen (NASDAQ: AMGN  ) over Onyx Pharmaceuticals (NASDAQ: ONXX  ) . On the one hand, the analyst thinks this is a war Pfizer can win. On the other hand, a win at, say, a $10 billion price, to acquire Onyx's potential $1 billion revenue stream (in 2015), would both add significantly to Pfizer's $5 billion net-debt load, while at the same time failing to move the needle much on Pfizer's $57 billion annual revenue stream.

Top 5 Managed Healthcare Companies To Invest In 2014: Silver Spruce Resources Inc (SSE)

Silver Spruce Resources Inc. is a junior exploration company. The Company�� operations consist of the exploration for precious and base minerals with a focus on uranium, mainly in the Central Mineral Belt of Labrador, which include Popes Hill, the Popes Hill JV with Great Western Minerals Group, and the MRT, RWM and Straits properties. The Company�� projects include Double Mer Property, Mount Benedict Property, Big Easy Property, MRT Property, Pope�� Hill area, Red Wine Mountains and Straits Property. The Snegamook Lake property is located just to the southeast of Snegamook Lake in central Labrador, in the western part of the Central Mineral Belt (CMB), consists of 86 claims. The Fishhawk lake is located to the southeast of Snegamook Lake in central Labrador, in the western part of the CMB, consists of 164 claims. On August 22, 2012, the Company purchased a uranium exploration property in the CMB of Labrador from Virginia Energy Resources Inc. Advisors' Opinion:

• [By Namitha Jagadeesh]

  SSE Plc (SSE) slid 5.8 percent to 1,489 pence as Citigroup said in a note that the supplier of gas and electricity would suffer the most from price caps or other forms of government intervention because it gets 97 percent of revenue from the U.K.

Top 5 Managed Healthcare Companies To Invest In 2014: Albemarle Corp (ALB)

Albemarle Corporation (Albemarle), incorporated in 1993, is a developer, manufacturer and marketer of specialty chemicals, which meet customer needs across a range of end markets, including the petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food-safety and custom chemistry services markets. As of December 31, 2011, the Company and its joint ventures operated 50 facilities, encompassing production, research and development facilities, and administrative and sales offices in North and South America, Europe, the Middle East, Asia, Africa and Australia. It serves approximately 3,000 customers in over 100 countries. It operates in three segments: Polymer Solutions, Catalysts and Fine Chemistry. On May 11, 2011, the Company acquired Catilin Inc. In October 2013, Albemarle Corp acquired Cambridge Chemical Co Ltd.

Polymer Solutions

The Company�� Polymer Solutions segment consists of two product market categories: flame retardants and stabilizers and curatives. Its products include plastic enclosures for consumer electronics, printed circuit boards, wire and cable, electrical connectors, textiles, foam insulation, and foam seating in furniture and automobiles. Its brominated flame retardants include products such as Saytex; its mineral-based flame retardants include products, such as Martinal and Magnifin, and its phosphorus-based flame retardants include products, such as Antiblaze and Ncendx.

The Company produces plastic additives, as well as other additives, such as curatives, antioxidants and stabilizers. Its additives products include curatives for polyurethane, polyurea, and epoxy system polymerization. This business also produces antioxidants and stabilizers. Its Ethacure curatives are used in cast elastomers, coatings, reaction injection molding (RIM) and specialty adhesives, which are incorporated into products, such as wheels, tires and rollers. Its line of Ethanox antioxi! dants is used by manufacturers of polyolefins to maintain physical properties during the manufacturing process, including the color of the final product. These antioxidants are found in applications, such as slit film, wire and cable, food packaging and pipes.

The Company produces antioxidants used in fuels and lubricants. Its line of Ethanox fuel and lubricant antioxidants is used by refiners and fuel marketers to extend fuel storage life and protect fuel systems, and by oil marketers and lubricant manufacturers to extend the useful life of lubricating oils, fluids and greases used in engines and various types of machinery. Its polymer solutions segment offers more than 80 products to a range of end-markets. It sells its products to chemical manufacturers and processors, such as polymer resin suppliers, lubricant manufacturers, refiners and other specialty chemical companies.

The Company competes with Chemtura Corporation, Israel Chemicals Ltd, Jiangsu Yoke Technology Co., Ltd., Zhejiang Wansheng Chemical Co., Ltd., J.M. Huber Corporation, Kyowa Chemical Industry Co., Ltd., Nabaltec GmbH, BASF Corporation, Chemtura Corporation and Songwon Industrial Co., Ltd.,

Catalysts

The Company�� Catalysts segment includes its refinery catalysts and catalyst solutions businesses. Its main refinery catalysts product lines are hydroprocessing catalysts (HPC), and fluidized catalytic cracking (FCC), catalysts and additives. HPC catalysts are used to reduce the quantity of sulfur and other impurities in petroleum products, as well as to convert feedstock into lighter products. FCC catalysts assist in the cracking of petroleum streams into derivative, higher-value products, such as fuels and petrochemical feedstock. Its FCC additives are used to remove sulfur in gasoline and to reduce emissions of sulfur dioxide and nitrogen oxide in FCC units. It offers approximately 130 different HPC catalysts products and approximately 40 different FCC catalysts and additives pro! ducts to ! its customers.

The Company has three business units in its performance catalyst solutions (PCS) division: polymer catalysts, chemical catalysts and electronic materials. It manufactures organometallic co-catalysts, as well as metallocene components and co-catalysts. It also offers finished Single-Site catalysts with or without its ActivCat technology and a range of Ziegler-Natta catalysts under the Advantage brand. Its co-catalysts and finished catalysts are used in its customers��production of polyolefin polymers. Such polymers are commodity (Ziegler Natta polymerization technology) and specialty (Single Site polymerization technology) plastics serving a range of end markets, including packaging, non-packaging, films and injection molding. Some of its organometallic products are also used in the manufacture of alpha-olefins (hexene, octane and decene). In electronic materials, it manufacture and sells metal organic products into electronic applications, such as the production of light emitting diodes (LEDs) for displays and general lighting, as well as other products used in the production of solar cells. Its chemical catalysts include a range of catalysts used in the chemical industry.

The Company competes with Criterion Catalysts and Technologies, W.R. Grace & Co./Advanced Refining Technologies, Haldor Topsoe, W.R. Grace & Co., BASF Corporation, AkzoNobel and Chemtura Corporation.

Fine Chemistry

The Company�� Fine Chemistry segment consists of two categories: performance chemicals, and fine chemistry services and intermediates. Performance chemicals include products, such as elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon and a range of bromine fine chemicals. Its products are used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing and other industrial applications. Other performance chemicals, wh! ich it pr! oduces include tertiary amines for surfactants, biocides, disinfectants and sanitizers; potassium-based products used in industrial applications; alkenyl succinic anhydride used in paper-sizing formulations, and aluminum oxides used in a range of refractory, ceramic and polishing applications. It sells these products to customers globally for use in personal care products, automotive insulation, foundry bricks and other industrial products.

The Company�� fine chemistry services business offers custom manufacturing, research and chemical scale-up services for companies. Its pharmaceutical bulk active is ibuprofen. Ibuprofen is used to provide pain relief and fever reduction. Bulk ibuprofen is formulated by pharmaceutical companies, which sells in both the prescription and over-the-counter markets. The Company also produces a range of intermediates used in the manufacture of a range of over-the-counter and prescription drugs.

The Company�� agrichemicals are sold to agrichemical manufacturers and distributors, which produce and distribute finished agricultural herbicides, insecticides, fungicides and soil fumigants. Its products include orthoalkylated anilines used in the acetanilide family of pre-emergent herbicides used with corn, soybeans and other crops and methyl bromide, which is used as a soil fumigant. It also manufactures and supplies a range of custom chemical intermediates for the agricultural industry.

The Company competes with Chemtura Corporation, Israel Chemicals, BASF Corporation, Lonza, Clariant Ltd. and Cilag AG.

Advisors' Opinion:

• [By Rich Duprey]

  Specialty chemicals maker�Albemarle� (NYSE: ALB  ) �announced yesterday a second-quarter dividend in the amount of $0.24 per share, the same rate it paid in February after having raised it from $0.20 per share in the prior quarter.